Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Private Trust Co. NA

Private Trust Co. NA grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,014 shares of the medical equipment provider’s stock after acquiring an additional 56 shares during the quarter. Private Trust Co. NA’s holdings in Intuitive Surgical were worth $529,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust boosted its position in shares of Intuitive Surgical by 2.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 747 shares of the medical equipment provider’s stock worth $390,000 after buying an additional 19 shares during the period. Verus Capital Partners LLC boosted its position in shares of Intuitive Surgical by 3.8% in the fourth quarter. Verus Capital Partners LLC now owns 1,032 shares of the medical equipment provider’s stock worth $539,000 after buying an additional 38 shares during the period. Linscomb Wealth Inc. purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth about $270,000. QRG Capital Management Inc. boosted its position in shares of Intuitive Surgical by 2.1% in the fourth quarter. QRG Capital Management Inc. now owns 72,842 shares of the medical equipment provider’s stock worth $38,020,000 after buying an additional 1,532 shares during the period. Finally, Versor Investments LP purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth about $248,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 1.7 %

Shares of NASDAQ ISRG opened at $573.15 on Friday. The stock’s 50 day moving average price is $569.87 and its two-hundred day moving average price is $529.06. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock has a market capitalization of $204.14 billion, a P/E ratio of 89.42, a PEG ratio of 5.85 and a beta of 1.39.

Analysts Set New Price Targets

ISRG has been the subject of several analyst reports. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Barclays upped their target price on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Raymond James increased their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Jefferies Financial Group increased their price target on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Finally, Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. One analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Insider Transactions at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 2,401 shares of the stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total value of $1,394,981.00. Following the sale, the executive vice president now owns 353 shares in the company, valued at $205,093. The trade was a 87.18 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 8,077 shares of company stock worth $4,620,025. 0.90% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.